"","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-8957275","R-HSA-8957275","Post-translational protein phosphorylation","14/59","108/10955",3.16990877657503e-16,9.89011538291409e-14,7.07390169088322e-14,"2243/3698/2335/116519/2266/348/4148/2719/174/6694/7018/335/336/197",14
"R-HSA-381426","R-HSA-381426","Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)","14/59","125/10955",2.60174435255619e-15,4.05872118998766e-13,2.90299896179954e-13,"2243/3698/2335/116519/2266/348/4148/2719/174/6694/7018/335/336/197",14
"R-HSA-114608","R-HSA-114608","Platelet degranulation ","13/59","129/10955",1.15790767035927e-13,1.20422397717364e-11,8.61320793390053e-12,"7057/2243/2335/2266/2244/2162/5345/6694/83706/7018/335/197/5341",13
"R-HSA-76005","R-HSA-76005","Response to elevated platelet cytosolic Ca2+","13/59","134/10955",1.90668503558146e-13,1.48721432775354e-11,1.0637295461665e-11,"7057/2243/2335/2266/2244/2162/5345/6694/83706/7018/335/197/5341",13
"R-HSA-216083","R-HSA-216083","Integrin cell surface interactions","9/59","85/10955",6.05759570135647e-10,3.77993971764644e-08,2.70360060776331e-08,"7057/2243/2335/2266/2244/1291/80781/375790/4060",9
"R-HSA-8963901","R-HSA-8963901","Chylomicron remodeling","5/59","10/10955",9.40804021476315e-10,4.41362641286621e-08,3.15684480272482e-08,"116519/348/335/336/344",5
"R-HSA-76002","R-HSA-76002","Platelet activation, signaling and aggregation","13/59","263/10955",9.90236695194342e-10,4.41362641286621e-08,3.15684480272482e-08,"7057/2243/2335/2266/2244/2162/5345/6694/83706/7018/335/197/5341",13
"R-HSA-975634","R-HSA-975634","Retinoid metabolism and transport","7/59","44/10955",2.98823259474428e-09,1.16541071195027e-07,8.33559618533929e-08,"348/2719/375790/335/336/55937/344",7
"R-HSA-6806667","R-HSA-6806667","Metabolism of fat-soluble vitamins","7/59","48/10955",5.64668016329773e-09,1.95751578994321e-07,1.40011250832646e-07,"348/2719/375790/335/336/55937/344",7
"R-HSA-8963899","R-HSA-8963899","Plasma lipoprotein remodeling","6/59","34/10955",2.24986909212586e-08,7.01959156743269e-07,5.02076050032298e-07,"116519/348/4018/335/336/344",6
"R-HSA-8963898","R-HSA-8963898","Plasma lipoprotein assembly","5/59","19/10955",4.1832464302822e-08,1.18652080568004e-06,8.48658605951988e-07,"348/335/336/341/344",5
"R-HSA-1474244","R-HSA-1474244","Extracellular matrix organization","12/59","300/10955",5.0557644577304e-08,1.3144987590099e-06,9.40194793893723e-07,"7057/2243/2335/2266/2244/1291/80781/4148/375790/4060/2192/2331",12
"R-HSA-174824","R-HSA-174824","Plasma lipoprotein assembly, remodeling, and clearance","7/59","75/10955",1.36018397794525e-07,3.26444154706859e-06,2.33489071517726e-06,"116519/348/4018/335/336/341/344",7
"R-HSA-8963888","R-HSA-8963888","Chylomicron assembly","4/59","10/10955",1.55547191014536e-07,3.46648025689538e-06,2.47939883421667e-06,"348/335/336/344",4
"R-HSA-354194","R-HSA-354194","GRB2:SOS provides linkage to MAPK signaling for Integrins ","4/59","15/10955",9.90922529295628e-07,1.93229893212647e-05,1.38207615928074e-05,"2243/2335/2266/2244",4
"R-HSA-372708","R-HSA-372708","p130Cas linkage to MAPK signaling for integrins","4/59","15/10955",9.90922529295628e-07,1.93229893212647e-05,1.38207615928074e-05,"2243/2335/2266/2244",4
"R-HSA-2187338","R-HSA-2187338","Visual phototransduction","7/59","106/10955",1.46759006859521e-06,2.69345942001003e-05,1.92649594143767e-05,"348/2719/375790/335/336/55937/344",7
"R-HSA-3000178","R-HSA-3000178","ECM proteoglycans","6/59","76/10955",3.07149127562145e-06,5.32391821107718e-05,3.80793070427922e-05,"2335/1291/4148/375790/4060/2331",6
"R-HSA-140875","R-HSA-140875","Common Pathway of Fibrin Clot Formation","4/59","22/10955",5.16295280607468e-06,8.47811197629105e-05,6.06396673068051e-05,"2243/2266/2244/2162",4
"R-HSA-196854","R-HSA-196854","Metabolism of vitamins and cofactors","8/59","191/10955",7.64171388344429e-06,0.000119210736581731,8.52654391205363e-05,"348/2719/375790/2194/335/336/55937/344",8
"R-HSA-3781865","R-HSA-3781865","Diseases of glycosylation","7/59","143/10955",1.07868679545928e-05,0.000160262038182521,0.000114627368740535,"7057/2719/375790/4060/2331/4758/11041",7
"R-HSA-354192","R-HSA-354192","Integrin signaling","4/59","27/10955",1.2140458270798e-05,0.000172173771840408,0.000123147232220534,"2243/2335/2266/2244",4
"R-HSA-8964058","R-HSA-8964058","HDL remodeling","3/59","10/10955",1.73357875415699e-05,0.000235163726650861,0.000168200776147039,"348/335/344",3
"R-HSA-6802948","R-HSA-6802948","Signaling by high-kinase activity BRAF mutants","4/59","36/10955",3.93019630249427e-05,0.000510925519324255,0.000365439305319642,"2243/2335/2266/2244",4
"R-HSA-5668914","R-HSA-5668914","Diseases of metabolism","8/59","249/10955",5.1834284543059e-05,0.000626563696161795,0.000448149472288463,"7057/2719/2328/375790/4060/2331/4758/11041",8
"R-HSA-140877","R-HSA-140877","Formation of Fibrin Clot (Clotting Cascade)","4/59","39/10955",5.42218583216938e-05,0.000626563696161795,0.000448149472288463,"2243/2266/2244/2162",4
"R-HSA-76009","R-HSA-76009","Platelet Aggregation (Plug Formation)","4/59","39/10955",5.42218583216938e-05,0.000626563696161795,0.000448149472288463,"2243/2335/2266/2244",4
"R-HSA-5674135","R-HSA-5674135","MAP2K and MAPK activation","4/59","40/10955",6.00052538770044e-05,0.000668629971772335,0.000478237361726502,"2243/2335/2266/2244",4
"R-HSA-3560782","R-HSA-3560782","Diseases associated with glycosaminoglycan metabolism","4/59","41/10955",6.62260683505828e-05,0.000712501149151097,0.000509616206545319,"2719/375790/4060/2331",4
"R-HSA-9656223","R-HSA-9656223","Signaling by RAF1 mutants","4/59","43/10955",8.00597378140286e-05,0.000832621273265898,0.000595532084792073,"2243/2335/2266/2244",4
"R-HSA-9749641","R-HSA-9749641","Aspirin ADME","4/59","44/10955",8.77131958164585e-05,0.000882790874023712,0.000631415874807783,"1559/1576/1558/11309",4
"R-HSA-5602498","R-HSA-5602498","MyD88 deficiency (TLR2/4)","3/59","17/10955",9.56339544812711e-05,0.000891709973210177,0.00063779525749176,"2243/2266/2244",3
"R-HSA-9018677","R-HSA-9018677","Biosynthesis of DHA-derived SPMs","3/59","17/10955",9.56339544812711e-05,0.000891709973210177,0.00063779525749176,"1559/1576/1558",3
"R-HSA-6802946","R-HSA-6802946","Signaling by moderate kinase activity BRAF mutants","4/59","47/10955",0.000113869351163758,0.000891709973210177,0.00063779525749176,"2243/2335/2266/2244",4
"R-HSA-6802949","R-HSA-6802949","Signaling by RAS mutants","4/59","47/10955",0.000113869351163758,0.000891709973210177,0.00063779525749176,"2243/2335/2266/2244",4
"R-HSA-6802955","R-HSA-6802955","Paradoxical activation of RAF signaling by kinase inactive BRAF","4/59","47/10955",0.000113869351163758,0.000891709973210177,0.00063779525749176,"2243/2335/2266/2244",4
"R-HSA-9024446","R-HSA-9024446","NR1H2 and NR1H3-mediated signaling","4/59","47/10955",0.000113869351163758,0.000891709973210177,0.00063779525749176,"348/2194/341/344",4
"R-HSA-9649948","R-HSA-9649948","Signaling downstream of RAS mutants","4/59","47/10955",0.000113869351163758,0.000891709973210177,0.00063779525749176,"2243/2335/2266/2244",4
"R-HSA-977606","R-HSA-977606","Regulation of Complement cascade","4/59","47/10955",0.000113869351163758,0.000891709973210177,0.00063779525749176,"730/727/1361/732",4
"R-HSA-5603041","R-HSA-5603041","IRAK4 deficiency (TLR2/4)","3/59","18/10955",0.000114321791437202,0.000891709973210177,0.00063779525749176,"2243/2266/2244",3
"R-HSA-9018678","R-HSA-9018678","Biosynthesis of specialized proresolving mediators (SPMs)","3/59","19/10955",0.00013523796115076,0.00102912789948871,0.000736083382900157,"1559/1576/1558",3
"R-HSA-5686938","R-HSA-5686938","Regulation of TLR by endogenous ligand","3/59","21/10955",0.00018420413437572,0.0013683735696482,0.00097872873402638,"2243/2266/2244",3
"R-HSA-211945","R-HSA-211945","Phase I - Functionalization of compounds","5/59","106/10955",0.000255030136777572,0.00183779852916448,0.00131448477794491,"1559/1576/1558/66002/2328",5
"R-HSA-166658","R-HSA-166658","Complement cascade","4/59","58/10955",0.000259176715651402,0.00183779852916448,0.00131448477794491,"730/727/1361/732",4
"R-HSA-9748784","R-HSA-9748784","Drug ADME","5/59","110/10955",0.000302997266471847,0.00210078104753814,0.00150258293548612,"1559/1576/1558/11309/2944",5
"R-HSA-211981","R-HSA-211981","Xenobiotics","3/59","25/10955",0.00031370768005294,0.00212775643861994,0.00152187707485637,"1559/1576/1558",3
"R-HSA-211897","R-HSA-211897","Cytochrome P450 - arranged by substrate type","4/59","66/10955",0.000426394232247941,0.00283053192470973,0.00202453700417835,"1559/1576/1558/66002",4
"R-HSA-2022854","R-HSA-2022854","Keratan sulfate biosynthesis","3/59","28/10955",0.000441729831542566,0.00287124390502668,0.00205365623436456,"4060/2331/11041",3
"R-HSA-6802952","R-HSA-6802952","Signaling by BRAF and RAF1 fusions","4/59","67/10955",0.000451655997290056,0.00287585043172444,0.00205695105103098,"2243/2335/2266/2244",4
"R-HSA-1630316","R-HSA-1630316","Glycosaminoglycan metabolism","5/59","124/10955",0.000526324521012981,0.003284265011121,0.00234906944115267,"2719/375790/4060/2331/11041",5
"R-HSA-5260271","R-HSA-5260271","Diseases of Immune System","3/59","31/10955",0.000599184993272893,0.00359510995963736,0.00257140118570553,"2243/2266/2244",3
"R-HSA-5602358","R-HSA-5602358","Diseases associated with the TLR signaling cascade","3/59","31/10955",0.000599184993272893,0.00359510995963736,0.00257140118570553,"2243/2266/2244",3
"R-HSA-1638074","R-HSA-1638074","Keratan sulfate/keratin metabolism","3/59","34/10955",0.000788576987562486,0.00464218905885841,0.00332032415815784,"4060/2331/11041",3
"R-HSA-8964043","R-HSA-8964043","Plasma lipoprotein clearance","3/59","37/10955",0.00101227314888676,0.00574234949913944,0.00410721354189461,"348/335/341",3
"R-HSA-9029569","R-HSA-9029569","NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux","3/59","37/10955",0.00101227314888676,0.00574234949913944,0.00410721354189461,"348/341/344",3
"R-HSA-6802957","R-HSA-6802957","Oncogenic MAPK signaling","4/59","84/10955",0.00106227720764785,0.00591840158546657,0.0042331347372433,"2243/2335/2266/2244",4
"R-HSA-211859","R-HSA-211859","Biological oxidations","6/59","222/10955",0.00119061414842207,0.00651704586504711,0.00466131485624152,"1559/1576/1558/66002/2328/2944",6
"R-HSA-211999","R-HSA-211999","CYP2E1 reactions","2/59","11/10955",0.0015201745904951,0.00817749090059431,0.00584894760771253,"1559/1558",2
"R-HSA-2022857","R-HSA-2022857","Keratan sulfate degradation","2/59","13/10955",0.0021410030105407,0.0113219142252322,0.00809799532978821,"4060/2331",2
"R-HSA-3656237","R-HSA-3656237","Defective EXT2 causes exostoses 2","2/59","14/10955",0.00248920610168809,0.0127316771102735,0.00910632775768552,"2719/375790",2
"R-HSA-3656253","R-HSA-3656253","Defective EXT1 causes exostoses 1, TRPS2 and CHDS","2/59","14/10955",0.00248920610168809,0.0127316771102735,0.00910632775768552,"2719/375790",2
"R-HSA-186797","R-HSA-186797","Signaling by PDGF","3/59","58/10955",0.00371080398316231,0.0186737232701071,0.0133563742687676,"7057/1291/7060",3
"R-HSA-3000171","R-HSA-3000171","Non-integrin membrane-ECM interactions","3/59","59/10955",0.00389476233608589,0.0192883468072825,0.0137959835463694,"7057/2335/375790",3
"R-HSA-2022377","R-HSA-2022377","Metabolism of Angiotensinogen to Angiotensins","2/59","18/10955",0.00412765772401923,0.0201223314045937,0.0143924907482249,"1522/1361",2
"R-HSA-3000480","R-HSA-3000480","Scavenging by Class A Receptors","2/59","19/10955",0.00459735416670963,0.0214085746270657,0.0153124757791428,"348/335",2
"R-HSA-8963889","R-HSA-8963889","Assembly of active LPL and LIPC lipase complexes","2/59","19/10955",0.00459735416670963,0.0214085746270657,0.0153124757791428,"116519/344",2
"R-HSA-9694614","R-HSA-9694614","Attachment and Entry","2/59","19/10955",0.00459735416670963,0.0214085746270657,0.0153124757791428,"2719/375790",2
"R-HSA-3560783","R-HSA-3560783","Defective B4GALT7 causes EDS, progeroid type","2/59","20/10955",0.00509056072405617,0.0223799923883047,0.0160072820051302,"2719/375790",2
"R-HSA-3560801","R-HSA-3560801","Defective B3GAT3 causes JDSSDHD","2/59","20/10955",0.00509056072405617,0.0223799923883047,0.0160072820051302,"2719/375790",2
"R-HSA-4420332","R-HSA-4420332","Defective B3GALT6 causes EDSP2 and SEMDJL1","2/59","20/10955",0.00509056072405617,0.0223799923883047,0.0160072820051302,"2719/375790",2
"R-HSA-71387","R-HSA-71387","Metabolism of carbohydrates","6/59","297/10955",0.00509288288323601,0.0223799923883047,0.0160072820051302,"2719/375790/4060/26007/2331/11041",6
"R-HSA-2024096","R-HSA-2024096","HS-GAG degradation","2/59","22/10955",0.00614647386422558,0.0266347200783108,0.0190504745499389,"2719/375790",2
"R-HSA-1971475","R-HSA-1971475","A tetrasaccharide linker sequence is required for GAG synthesis","2/59","26/10955",0.00852920015016538,0.0364535677650904,0.0260734020452064,"2719/375790",2
"R-HSA-3000170","R-HSA-3000170","Syndecan interactions","2/59","27/10955",0.00917986311350505,0.0387042877218051,0.0276832287348943,"7057/2335",2
"R-HSA-2022928","R-HSA-2022928","HS-GAG biosynthesis","2/59","31/10955",0.0119951125237878,0.0498996680989574,0.0356907207725337,"2719/375790",2
